| __timestamp | Agios Pharmaceuticals, Inc. | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 19120000 | 305409000 |
| Thursday, January 1, 2015 | 35992000 | 377080000 |
| Friday, January 1, 2016 | 50714000 | 432829000 |
| Sunday, January 1, 2017 | 71124000 | 496079000 |
| Monday, January 1, 2018 | 114145000 | 557616000 |
| Tuesday, January 1, 2019 | 132034000 | 658498000 |
| Wednesday, January 1, 2020 | 149070000 | 770456000 |
| Friday, January 1, 2021 | 121445000 | 840100000 |
| Saturday, January 1, 2022 | 121673000 | 944700000 |
| Sunday, January 1, 2023 | 119903000 | 1136600000 |
| Monday, January 1, 2024 | 156784000 | 1464300000 |
Unlocking the unknown
In the competitive world of biotechnology, managing operational costs is crucial for success. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Vertex Pharmaceuticals Incorporated and Agios Pharmaceuticals, Inc. from 2014 to 2023. Over this period, Vertex consistently outspent Agios, with its SG&A expenses growing by approximately 270%, reaching over $1.1 billion in 2023. In contrast, Agios saw a more modest increase of around 525%, peaking at $149 million in 2020 before slightly declining. This trend highlights Vertex's aggressive investment in administrative and sales functions, possibly reflecting its expansive market strategy. Meanwhile, Agios's steadier growth suggests a more conservative approach. Understanding these financial strategies provides insight into each company's operational priorities and market positioning.
Comparing SG&A Expenses: Vertex Pharmaceuticals Incorporated vs Alnylam Pharmaceuticals, Inc. Trends and Insights
Who Optimizes SG&A Costs Better? Vertex Pharmaceuticals Incorporated or Incyte Corporation
Vertex Pharmaceuticals Incorporated and Bio-Techne Corporation: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Vertex Pharmaceuticals Incorporated or Alpine Immune Sciences, Inc.
Breaking Down SG&A Expenses: Vertex Pharmaceuticals Incorporated vs MannKind Corporation
Breaking Down SG&A Expenses: Exelixis, Inc. vs Agios Pharmaceuticals, Inc.
Jazz Pharmaceuticals plc or Agios Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Lantheus Holdings, Inc. vs Agios Pharmaceuticals, Inc.: SG&A Expense Trends
Apellis Pharmaceuticals, Inc. and Agios Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Merus N.V. and Agios Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Supernus Pharmaceuticals, Inc. vs Agios Pharmaceuticals, Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Mesoblast Limited and Agios Pharmaceuticals, Inc.